ASO Author Reflections: Evolution of Gastric Cancer Care at Tata Memorial Centre—Best of the East and the West

go back to reference Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49.CrossRefPubMed Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49.CrossRefPubMed

go back to reference Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019;393:1948–57.CrossRefPubMed Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019;393:1948–57.CrossRefPubMed

go back to reference Kim HH, Hyung WJ, Cho GS, Kim MC, Han SU, Kim W, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report—a phase III multicenter, prospective, randomized trial (KLASS trial). Ann Surg. 2010;251(3):417–20. https://doi.org/10.1097/SLA.0b013e3181cc8f6b. Kim HH, Hyung WJ, Cho GS, Kim MC, Han SU, Kim W, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report—a phase III multicenter, prospective, randomized trial (KLASS trial). Ann Surg. 2010;251(3):417–20. https://​doi.​org/​10.​1097/​SLA.​0b013e3181cc8f6b​.

go back to reference Batra S, Bhandare MS, Chaudhari VA, et al. 1657 Resected gastric adenocarcinomas at a single institution: outcomes and trends over 17 years. Ann Surg Oncol. 2024;16:1–15. https://doi.org/10.1245/s10434-024-15842-4.CrossRef Batra S, Bhandare MS, Chaudhari VA, et al. 1657 Resected gastric adenocarcinomas at a single institution: outcomes and trends over 17 years. Ann Surg Oncol. 2024;16:1–15. https://​doi.​org/​10.​1245/​s10434-024-15842-4.CrossRef

go back to reference Shrikhande SV, Ramadwar M, Goel M, Mehta S, Shetty NS, et al. Phase III randomized controlled trial comparing D2 versus D3 lymphadenectomy on outcomes of non-metastatic, resectable, but locally advanced, gastric cancer following neoadjuvant (perioperative) chemotherapy (ELANCe trial). 2000 Feb 29 ed. Bethesda: National Library of Medicine (US); 2013. Shrikhande SV, Ramadwar M, Goel M, Mehta S, Shetty NS, et al. Phase III randomized controlled trial comparing D2 versus D3 lymphadenectomy on outcomes of non-metastatic, resectable, but locally advanced, gastric cancer following neoadjuvant (perioperative) chemotherapy (ELANCe trial). 2000 Feb 29 ed. Bethesda: National Library of Medicine (US); 2013.